FDA Inspection 888168 — Aino Co., Ltd. Of North China Pharma. Group
The FDA completed an inspection of Aino Co., Ltd. Of North China Pharma. Group on Jun 6, 2014 in Shijiazhuang, Hebei. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 6, 2014
- Fiscal Year
- 2014
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Shijiazhuang, Hebei (China)